Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Swedish Oat Fiber is a specialized manufacturer of high-quality oat-based ingredients, focusing on the extraction of bioactive components for the food, beverage, and nutraceutical industries. The company is best known for its proprietary, chemical-free fractionation process that produces oat beta-glucans, oat oils, and oat proteins from non-GMO Swedish oats. Its flagship product, PromOat, is a soluble fiber clinically recognized for its ability to lower cholesterol and manage blood glucose levels. Headquartered in Bua, Sweden, the company serves a global market seeking functional ingredients with scientifically backed health claims. In 2017, Swedish Oat Fiber was acquired by Tate & Lyle, integrating its specialized oat technology into a broader global health and wellness portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Swedish Oat Fiber.